Recently, accumulating evidence has shown that IL-17-positive cells are frequently present in multiple cancers, including prostate cancer [25], colorectal cancer [26], hepatocellular carcinoma [27], breast cancer [28], ovarian cancer [20] and non-small-cell lung cancer [29]. This evidence concerns the gene IL17A and ovarian carcinoma.